Gerontological Society of America Applauds Introduction of Treat and Reduce Obesity Act

The Gerontological Society of America(GSA) commends Senators Bill Cassidy, MD, and Ben Ray Lujan for introducing the Treat and Reduce Obesity Act of 2025. This legislation is critical for providing Medicare beneficiaries with access to comprehensive obesity care including anti-obesity medications (AOMs) and intensive behavioral therapy (IBT).

Ewell Joins Gerontological Society of America’s Board of Directors

The Gerontological Society of America (GSA) — the nation’s oldest and largest interdisciplinary organization focused on aging — has named Stephen Ewell, MBA, MS, of the Consumer Technology Association Foundation as an at-large member of its Board of Directors.

GSA Statement on Medicare and Medicaid Coverage of Anti-Obesity Medications

On April 4, the Centers for Medicare and Medicaid Services (CMS) issued a final rule regarding “Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly.” The rule included a statement that CMS did not intend to finalize “Part D Coverage of Anti-Obesity Medications (AOMs),” meaning Medicare and Medicaid would not cover AOMs in Contract Year 2026. CMS noted it would “continue to consider the extent to which it may be appropriate to engage in future rulemaking in this area.”

First34568101112Last